These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 23217380)

  • 1. Biomarkers for diabetes prediction, diagnosis and personalized therapy.
    Chen HB; Jia WP
    Chin Med J (Engl); 2012 Dec; 125(23):4163-6. PubMed ID: 23217380
    [No Abstract]   [Full Text] [Related]  

  • 2. Circulating microRNAs: possible prediction biomarkers for personalized therapy of non-small-cell lung carcinoma.
    Gao W; Liu L; Lu X; Shu Y
    Clin Lung Cancer; 2011 Jan; 12(1):14-7. PubMed ID: 21273174
    [No Abstract]   [Full Text] [Related]  

  • 3. Multimodal dynamic profiling of healthy and diseased states for future personalized health care.
    Mias GI; Snyder M
    Clin Pharmacol Ther; 2013 Jan; 93(1):29-32. PubMed ID: 23187877
    [No Abstract]   [Full Text] [Related]  

  • 4. Personalized prognosis and diagnosis of type 2 diabetes--vision or fiction?
    Müller G
    Pharmacology; 2010; 85(3):168-87. PubMed ID: 20173359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The personalized medicine revolution: getting it right for children.
    Burckart GJ; Green DJ
    Pediatr Transplant; 2012 Sep; 16(6):530-2. PubMed ID: 22225514
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiple sclerosis: individualized disease susceptibility and therapy response.
    Pravica V; Markovic M; Cupic M; Savic E; Popadic D; Drulovic J; Mostarica-Stojkovic M
    Biomark Med; 2013 Feb; 7(1):59-71. PubMed ID: 23387485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mining of protein based biomarkers for type 2 diabetes mellitus.
    Khan AR; Awan FR
    Pak J Pharm Sci; 2012 Oct; 25(4):889-901. PubMed ID: 23010011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs in cancer: personalizing diagnosis and therapy.
    Nana-Sinkam SP; Fabbri M; Croce CM
    Ann N Y Acad Sci; 2010 Oct; 1210():25-33. PubMed ID: 20973796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalized medicine: predicting the risk of complications of cancer therapy.
    Epstein JB
    Oral Dis; 2013 Oct; 19(7):633-4. PubMed ID: 23796427
    [No Abstract]   [Full Text] [Related]  

  • 10. Nanobiotechnology and personalized medicine.
    Jain KK
    Prog Mol Biol Transl Sci; 2011; 104():325-54. PubMed ID: 22093223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Establishment of novel biomarkers for Personalized medication for atopic dermatitis].
    Ohta S; Taniguchi K; Arima K; Suzuki S; Shiraishi H; Masuoka M; Izuhara K
    Rinsho Byori; 2013 Mar; 61(3):247-55. PubMed ID: 23785795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new trend in personalized medicine: rapid detection of SNPs in drug transporter genes by the SmartAmp method.
    Aw W; Lezhava A; Hayashizaki Y; Ishikawa T
    Clin Pharmacol Ther; 2011 Apr; 89(4):617-20. PubMed ID: 21346755
    [No Abstract]   [Full Text] [Related]  

  • 13. Biomarkers and personalized psychiatry.
    Roffman JL
    Harv Rev Psychiatry; 2011; 19(3):99-101. PubMed ID: 21631156
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of rs769217 and rs1001179 polymorphisms of catalase gene on blood catalase, carbohydrate and lipid biomarkers in diabetes mellitus.
    Góth L; Nagy T; Kósa Z; Fejes Z; Bhattoa HP; Paragh G; Káplár M
    Free Radic Res; 2012 Oct; 46(10):1249-57. PubMed ID: 22712453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Personalized medicine' to identify genetic risks for type 2 diabetes and focus prevention: can it fulfill its promise?
    Spiegel AM; Hawkins M
    Health Aff (Millwood); 2012 Jan; 31(1):43-9. PubMed ID: 22232093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetic study toward personalized medicine for diabetes mellitus].
    Maeda S
    Nihon Rinsho; 2012 May; 70 Suppl 3():579-84. PubMed ID: 22768582
    [No Abstract]   [Full Text] [Related]  

  • 17. Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study.
    Kong L; Zhu J; Han W; Jiang X; Xu M; Zhao Y; Dong Q; Pang Z; Guan Q; Gao L; Zhao J; Zhao L
    Acta Diabetol; 2011 Mar; 48(1):61-9. PubMed ID: 20857148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycemic biomarkers as tools for diagnosis and monitoring of diabetes.
    Gupta MK
    MLO Med Lab Obs; 2013 Mar; 45(3):8, 10, 12; quiz 14. PubMed ID: 23822027
    [No Abstract]   [Full Text] [Related]  

  • 19. The pleomorphism of systemic sclerosis: are we ready for 'personalized medicine' in scleroderma?
    Steen VD
    Expert Rev Clin Immunol; 2011 Jul; 7(4):403-5. PubMed ID: 21790281
    [No Abstract]   [Full Text] [Related]  

  • 20. Proteomic identification of salivary biomarkers of type-2 diabetes.
    Rao PV; Reddy AP; Lu X; Dasari S; Krishnaprasad A; Biggs E; Roberts CT; Nagalla SR
    J Proteome Res; 2009 Jan; 8(1):239-45. PubMed ID: 19118452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.